Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.
Versluis J, Pandey M, Flamand Y, Haydu JE, Belizaire R, Faber M, Vedula RS, Charles A, Copson KM, Shimony S, Rozental A, Bendapudi PK, Wolach O, Griffiths EA, Thompson JE, Stone RM, DeAngelo DJ, Neuberg D, Luskin MR, Wang ES, Lindsley RC.
Versluis J, et al. Among authors: shimony s.
Blood Adv. 2022 May 10;6(9):2835-2846. doi: 10.1182/bloodadvances.2021006166.
Blood Adv. 2022.
PMID: 35081257
Free PMC article.